JAMA Network Open
Original Investigation
Pathology and Laboratory Medicine
September 29, 2020
Graeme Eisenhofer, PhD; Claudio Durán, MS; Carlo Vittorio Cannistraci, PhD; Mirko Peitzsch, PhD; Tracy Ann Williams, PhD; Anna Riester, MD; Jacopo Burrello, MD; Fabrizio Buffolo, MD; Aleksander Prejbisz, MD; Felix Beuschlein, MD; Andrzej Januszewicz, MD; Paolo Mulatero, MD; Jacques W. M. Lenders, MD; Martin Reincke, MD
open access
JAMA Netw Open. 2020; 3(9):e2016209. doi: 10.1001/jamanetworkopen.2020.16209
This diagnostic study assesses whether plasma steroid profiling combined with machine learning facilitates diagnosis and treatment stratification of patients with primary aldosteronism, particularly those with unilateral adenomas due to pathogenic KCNJ5 sequence variants.
JAMA Oncology
Original Investigation
October 1, 2019
Guillaume Assié, MD, PhD; Anne Jouinot, MD; Martin Fassnacht, MD, PhD; Rossella Libé, MD; Simon Garinet, PharmD; Louis Jacob, BS; Nadim Hamzaoui, MD; Mario Neou, MS; Julien Sakat, MD; Bruno de La Villéon, MD; Karine Perlemoine, BS; Bruno Ragazzon, PhD; Mathilde Sibony, MD; Frédérique Tissier, MD; Sébastien Gaujoux, MD, PhD; Bertrand Dousset, MD, PhD; Silviu Sbiera, MD, PhD; Cristina L. Ronchi, MD, PhD; Matthias Kroiss, MD, PhD; Esther Korpershoek, PhD; Ronald De Krijger, MD, PhD; Jens Waldmann, MD, PhD; Marcus Quinkler, MD, PhD; Magalie Haissaguerre, MD, PhD; Antoine Tabarin, MD, PhD; Olivier Chabre, MD, PhD; Michaela Luconi, MD, PhD; Massimo Mannelli, MD, PhD; Lionel Groussin, MD, PhD; Xavier Bertagna, MD, PhD; Eric Baudin, MD, PhD; Laurence Amar, MD, PhD; Joel Coste, MD, PhD; Felix Beuschlein, MD, PhD; Jérôme Bertherat, MD, PhD
free access
JAMA Oncol. 2019; 5(10):1440-1447. doi: 10.1001/jamaoncol.2019.1558
This biomarker analyss of patients with adrenocortical carcinoma compares the molecular classification for prognostic assessment of adrenocortical carcinoma with other known prognostic factors.